| Date Filed | Type | Description |
| 10/05/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 08/17/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 07/07/2023 |
SC 13G/A
| BlackRock Inc. reports a 2.4% stake in Kronos Bio, Inc. |
| 07/07/2023 |
4
| Dinsmore Christopher (Chief Scientific Officer) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Sold 6,634 shares
@ $1.7523, valued at
$11.6k
|
|
| 07/07/2023 |
4
| DiMartino Jorge (Chief Medical Officer & VP) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Sold 10,818 shares
@ $1.7523, valued at
$19k
|
|
| 07/07/2023 |
4
| Al-Wakeel Yasir B. (CFO) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Sold 9,617 shares
@ $1.7523, valued at
$16.9k
|
|
| 05/30/2023 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/30/2023 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/10/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/10/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 04/27/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/27/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/27/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/24/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/24/2023 |
8-K
| Quarterly results |
| 03/27/2023 |
8-K
| Quarterly results |
| 03/27/2023 |
8-K/A
| Quarterly results |
| 03/15/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/15/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/15/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 02/24/2023 |
4
| Dinsmore Christopher (Chief Scientific Officer) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Sold 6,291 shares
@ $1.7355, valued at
$10.9k
|
|
| 02/24/2023 |
4
| DiMartino Jorge (Chief Medical Officer & VP) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Sold 10,153 shares
@ $1.7355, valued at
$17.6k
|
|
| 02/24/2023 |
4
| Al-Wakeel Yasir B. (CFO) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Sold 9,026 shares
@ $1.7355, valued at
$15.7k
|
|
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 2.6% stake in Kronos Bio Inc. |
| 02/01/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/26/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/09/2023 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure Interactive Data |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|